Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uberto Fumagalli

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
Journal of Gastrointestinal Cancer|November 7, 2019
How Should We Measure the Quality of Lymphadenectomy for Gastric Cancer? Anatomical Versus Numerical CriterionStefano Rausei, Federica Galli, Georgios Lianos, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 23, 2021
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancerAnnamaria Agnes, Alberto Biondi, Roberto Persiani, et al.
Gut|December 5, 2023
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomyGuy Boeckxstaens, Stefanie Elsen, Ann Belmans, et al.
Clinical Nuclear Medicine|January 25, 2020
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) ExperiencePaolo Morgagni, Maria Bencivenga, Eleonora Colciago, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2022
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort studyLeonardo Solaini, Maria Bencivenga, Alessia D'ignazio, et al.
Therapeutic Advances in Medical Oncology|July 31, 2020
Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer centerMaria Saveria Rotundo, Maria Giulia Zampino, Paola Simona Ravenda, et al.
Journal of Surgical Oncology|November 25, 2020
Multidimensional Prognostic Index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: The FRAGIS studyGiacomo Pata, Luca Bianchetti, Matteo Rota, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 10, 2018
An aggressive early gastric cancer: Kodama's PenA typePaolo Morgagni, Leonardo Solaini, Luca Saragoni, et al.
Tumori|July 8, 2021
Neobladder and ablative pelvic radiotherapy: still a taboo?Luca Bergamaschi, Marianna Alessandra Gerardi, Mattia Zaffaroni, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 23, 2024
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer modelsElisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
Journal of Gastrointestinal Cancer|November 7, 2019
How Should We Measure the Quality of Lymphadenectomy for Gastric Cancer? Anatomical Versus Numerical CriterionStefano Rausei, Federica Galli, Georgios Lianos, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 23, 2021
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancerAnnamaria Agnes, Alberto Biondi, Roberto Persiani, et al.
Gut|December 5, 2023
10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomyGuy Boeckxstaens, Stefanie Elsen, Ann Belmans, et al.
Clinical Nuclear Medicine|January 25, 2020
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) ExperiencePaolo Morgagni, Maria Bencivenga, Eleonora Colciago, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2022
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort studyLeonardo Solaini, Maria Bencivenga, Alessia D'ignazio, et al.
Therapeutic Advances in Medical Oncology|July 31, 2020
Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer centerMaria Saveria Rotundo, Maria Giulia Zampino, Paola Simona Ravenda, et al.
Journal of Surgical Oncology|November 25, 2020
Multidimensional Prognostic Index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: The FRAGIS studyGiacomo Pata, Luca Bianchetti, Matteo Rota, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 10, 2018
An aggressive early gastric cancer: Kodama's PenA typePaolo Morgagni, Leonardo Solaini, Luca Saragoni, et al.
Tumori|July 8, 2021
Neobladder and ablative pelvic radiotherapy: still a taboo?Luca Bergamaschi, Marianna Alessandra Gerardi, Mattia Zaffaroni, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 23, 2024
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer modelsElisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, et al.
Pageof 13